Our Recommendations
New Publications
- Two decades of public health achievements in lymphatic filariasis (2000–2020): reflections, progress and future challenges (2021)
- Progress towards elimination of lymphatic filariasis in the Eastern Mediterranean Region (2021)
- Progress and impact of 20 years of a lymphatic filariasis elimination programme in South-East Asia (2021)
- Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis (2021)
- African regional progress and status of the programme to eliminate lymphatic filariasis: 2000–2020 (2021)
Filter
14
Featured
Language
Document type
Studies & Reports
14
Countries / Regions
Global
3
Ghana
1
Africa
1
Latin America and the Carribbean
1
Saudi Arabia
1
Western Pacific Region
1
Djibouti
1
Egypt
1
Sudan
1
Yemen
1
Zambia
1
Somalia
1
India
1
Authors & Publishers
Publication Years
Category
Countries
4
Studies & Reports
1
Toolboxes
Le but de cette note de concept est donc de définir Ie rôle de I'APOC dans I'élimination de l'onchocercose, ainsi que sa contribution aux efforts visant à éliminer la filariose
Iymphatique et d'autres maladies tropicales négligées ciblées, et au renforcement des
systèmes de santé au nive...
Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of c...
The South-East Asia regional programme to eliminate lymphatic filariasis (LF) was launched in 2000. This study presents the progress and impact of the programme in the region.
To eliminate lymphatic filariasis (LF) by 2020, the World Health Organization (WHO) has launched a campaign against the disease. Since the launch in 2000, significant progress has been made to achieve this ambitious goal. In this article we review the progress and status of the LF programme in Afric...
Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) or DA (diethylcarbamazine and ...
Lymphatic filariasis (LF) infection if untreated results in fluid accumulation in the limbs or breasts (lymphedema) or genitalia (hydrocele) that is painful and causes great discomfort. Morbidity management and disability prevention (MMDP) strategies such as surgery for hydrocele, treatment of acute...
The Western Pacific Region is the largest and most diverse region in the world, made up of 37 countries and territories in the Pacific, Oceania and parts of Asia, with a population of more than 1.9 billion people stretching over an area from China and Mongolia in the north to New Zealand in the sout...
In South and Central America, lymphatic filariasis (LF) is caused by Wuchereria bancrofti, which is transmitted by Culex quinquefasciatus, the only vector species in this region. Of the seven countries considered endemic for LF in the Americas in the last decade, Costa Rica, Suriname and Trinidad a...
Lymphatic filariasis (LF), a neglected tropical disease, is targeted for global elimination as a public health problem. This article reviews the history of LF control and elimination activities in the countries of the World Health Organization's (WHO) Eastern Mediterranean Region (EMR) over the last...
Analysis of microfilaria prevalence data from 430 communities
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
We are pleased to provide an editorial to introduce this series of articles on the achievements of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) over the last 2 decades. We
are delighted that so many of the major players in this journey have agreed to contribute to this supplement,...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
